DGAP-News: MeVis Medical Solutions AG

DGAP-News: MeVis Medical Solutions AG: MeVis Q1 2016: Solid start into the new year

DGAP-News: MeVis Medical Solutions AG / Key word(s): Quarter Results/Interim Report MeVis Medical Solutions AG: MeVis Q1 2016: Solid start into the new year

24.05.2016 / 09:30 The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Again improvement in revenues in the Digital Mammography segment

- Revenues in the first quarter grown by 14% to EUR 3.9 m (prev. year EUR 3.4 m)

- Earnings before interest and taxes (EBIT) increased by EUR 0.6 m to EUR 1.2 m, 31 % EBIT margin

- Financial result declined by just under EUR 1.0 m to EUR -0.9 m

Bremen, May 24, 2016 - MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], a leading provider of medical imaging software, today announced its figures for the first quarter in 2016.

Sales in the first quarter of 2016 came to EUR 3,876 k, up 14 % on the first quarter of 2015 (prev. year EUR 3,408 k). The sales growth of EUR 468 k is largely due to maintenance revenues which have increased since mid-2015. Sales in the new license business improved by a satisfactory 9 % to EUR 1,701 k, while sales in the maintenance business increased by 27 % to EUR 1,889 k, now accounting for 49 % of total sales. Sales in the Digital Mammography segment were up by 16 % to EUR 3,145 k (prev. year: EUR 2,721 k), while sales in the Other Diagnostics segment improved slightly by 6 % to EUR 731 k (prev. year: EUR 687 k).

Operating costs in the first quarter of 2016 fell slightly due to a slight drop in staff costs and on the back of other operating expenses. Staff costs decreased by 2 % in the first quarter. Other operating expenses in the first quarter declined to EUR 529 k compared to the previous year's quarter (prev. year: EUR 549 k).

After depreciation and amortization of EUR 448 k (down 21 % year on year primarily due to lower scheduled amortization of capitalized development costs), EBIT (earnings before interest and taxes) amounted to EUR 1,183 k in the period under review (up a significant 118 % on the previous year's figure of EUR 542 k) and an EBIT margin of 31 % (prev. year: 16 %).

The financial result deteriorated by EUR -997 k year on year to EUR -859 k. Negative effects from the US Dollar exchange rate combined with a higher share of liquidity in US dollars were largely responsible for this.

Due to the fiscal unity which became effective as of January 1, 2016, the tax result amounted to EUR 0 k (prev. year: expense of EUR 42 k).

After-tax earnings consequently fell by EUR 315 k to EUR 324 k, which is equivalent to undiluted earnings per share of EUR 0.18 (prev. year: EUR 0.37).

The financial reports of the Company can be downloaded from the following website: http://www.mevis.de/en/investor-relations/financial-reports/

---------------------------------------------------------------------------

24.05.2016 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

---------------------------------------------------------------------------

Language: English Company: MeVis Medical Solutions AG Caroline-Herschel-Str. 1 28359 Bremen Germany Phone: +49 421 224 95 0 Fax: +49 421 224 95 999 E-mail: ir@mevis.de Internet: http://www.mevis.de ISIN: DE000A0LBFE4 WKN: A0LBFE Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Munich, Stuttgart End of News DGAP News Service ---------------------------------------------------------------------------

465049 24.05.2016